Cambridge Healthtech Institute’s 17th Annual
Recombinant Protein Expression and Production
Achieving Quality and Quantity
January 21-22, 2015
Biopharmaceuticals currently represent the fastest-growing sector of the pharmaceutical industry, driven by a rapid expansion in the manufacture of recombinant protein-based drugs. To meet the demand, it is crucial to increase the throughput of expression, production and purification processes and systems.
Cambridge Healthtech Institute’s Recombinant Protein Expression and Production conference explores the newest data and innovations relating to the best choices in hosts/systems, as well as ways to revive existing systems and make them work more effectively to produce the quality and quantity of the desired biotherapeutic.
Effect of Ambient Light on Monoclonal Antibody Product Quality during Small-Scale Mammalian Cell Culture Process in Clear Glass Bioreactors
Mary Mallaney, Engineer I, Purification Development, Genentech, Inc.
Optimizing the Cell Line Development Workflow to Support Accelerated Timelines
Christine DeMaria, Ph.D., Associate Director, Therapeutic Protein Expression, Global Biotherapeutics Development, Sanofi US
The Rapid Generation of Multiple Antibody Toxin Conjugates: Expression in Eukaryotic Algae
Miller Tran, Ph.D., Senior Scientist, Lead Discovery, Verdant Therapeutics, Inc.
Taking Protein Production in Escherichia coli to the Next Level
David Vikström, Ph.D., CTO, Xbrane Bioscience
Designer Surfactant-Like Self-Assembling Peptides for Membrane Protein Purification and Stabilization
Sotirios Koutsopoulos, Ph.D., Research Scientist, Center for Biomedical Engineering, Massachusetts Institute of Technology
Production of Human Integral Membrane Proteins in Mammalian Cells
James D. Love, Ph.D., Director, Technology Development, Biochemistry, Albert Einstein College of Medicine
Advances for Maximizing Protein Yields in HEK293 and CHO Transient Expression
Henry C. Chiou, Ph.D., Associate Director, Life Science Solutions, Thermo Fisher Scientific
Omics-Guided Cell Line Engineering: Reducing High Mannose by Overexpressing N-Glycosylation Pathway Regulators
Shivani Gupta, Ph.D., Associate Scientist, Cell Line Development, Amgen, Inc.
Mammalian Systems and Synthetic Biotechnology for Recombinant Protein Production
Dong-Yup Lee, Ph.D., Assistant Professor, Chemical and Biomolecular Engineering, National University of Singapore; Senior Research Scientist, Bioprocessing Technology Institute, A*STAR
Improving CHO Cell Factories Using Systems Biology and Genome Editing Technologies
Helene Faustrup Kildegaard, Ph.D., Co-Principal Investigator, Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark
Increasing Monoclonal Antibody Production Using Low-Intensity Pulsed Ultrasound
Jie Chen, Ph.D., Professor, Electrical and Computer Engineering, University of Alberta, Edmonton